Press Room - Sanofi US News

Menu

Media Room Menu

Month Year

Month Year

Nov 11, 2009

Sanofi Pasteur Announces Final Results of U.S. Clinical Trials of Influenza A (H1N1) Vaccine in Adults and Children

Final data confirm immunogenicity, safety profile
Nov 2, 2009

Sanofi Pasteur Presents Safety Data on Menactra® Vaccine Given to Infants at Infectious Disease Society Meeting

The two-dose meningococcal quadrivalent conjugate vaccine was generally well-tolerated
Oct 30, 2009

Sanofi-aventis Delivers a Solid Performance in Third Quarter 2009
Oct 29, 2009

Sanofi-aventis U.S. Appoints Patrick McLain Vice President, U.S. Federal Government Affairs and Policy
Oct 16, 2009

FDA Approves Elitek® (rasburicase) for Management of Plasma Uric Acid Levels in Adults with Leukemia, Lymphoma, and Solid Tumors Receiving Anti-Cancer Therapy

- Elitek is now approved to manage a potentially life-threatening complication associated with anti-cancer treatment in adults -

Show per page

Print
Email page
RSS

You are about to leave www.sanofi.us

If you wish to continue to this external website, click Proceed. It is provided for information only. Sanofi assumes no responsibility for the information presented on this website.